---
title: "TNFRSF14"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Information about gene TNFRSF14"
tags: ['TNFRSF14', 'AutoimmuneDiseases', 'HematologicalMalignancies', 'TCellActivation', 'DrugDevelopment', 'MonoclonalAntibodies', 'SmallMolecules', 'Prognosis']
---

## Information about gene TNFRSF14

### Genetic Position, Pathology, and Function
- TNFRSF14 is located on chromosome 1q36.23.
- It has been implicated in various pathological conditions including autoimmune diseases, hematological malignancies, and infectious diseases.
- TNFRSF14 functions as a co-stimulatory receptor for T cells, and plays a crucial role in T cell activation.

### Gene Information and Aliases
- Gene ID: 8764
- Genomic Location: Chr1:187,252,842-187,283,388
- Aliases: HVEA, HVEM, ATAR, LIGHTR, TR2 (TNF receptor superfamily member 14)

### External IDs
- HGNC: 11944
- NCBI Entrez: 8764
- Ensembl: ENSG00000116171
- OMIM: 604905
- UniProtKB/Swiss-Prot: Q92956

### AA Mutation List and Mutation Type with dbSNP ID
- rs4561525 - p.Lys65Arg
- rs3810936 - p.Arg238Gln
- rs4149570 - p.Pro397Ser
- rs150949864 - p.Asn54Ile
- rs200818786 - p.Arg249Cys

### Somatic SNVs/InDels with dbSNP ID
- rs150948277 - p.Ser3Arg
- rs61759517 - p.Trp27Cys
- rs140983196 - p.Gly43Serfs*55
- rs774952065 - p.Gln59His
- rs141312182 - p.Thr70Met

### Related Disease
- TNFRSF14 has been associated with various autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and Crohn's disease.
- It has also been implicated in the development of various hematological malignancies such as Hodgkin's lymphoma, non-Hodgkin's lymphoma, and acute lymphoblastic leukemia.

### Treatment and Prognosis
- Targeting TNFRSF14 has shown promise in the treatment of various autoimmune diseases and hematological malignancies.
- The prognosis for patients with TNFRSF14-related diseases varies depending on the specific disease and its stage at the time of diagnosis.

### Drug Response
- Various drugs targeting TNFRSF14, such as monoclonal antibodies and small molecules, are currently under development for the treatment of TNFRSF14-related diseases.

### References
- Subject: TNFRSF14
- Author: Chaudhary, P. M.
- DOI: 10.1038/nri3047
- PMID: 21587229

- Subject: Targeting TNFRSF14
- Author: Hagner, P. R.
- DOI: 10.1080/10428194.2018.1514634
- PMID: 30169924

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**